Sunda Energy (AIM: SNDA) shares surged 25% after the company updated investors on its acquisition of New Zealand oil producer Matahio NZ, confirming the transaction remains on track to complete
Sunda Energy (AIM: SNDA) shares surged 25% after the company updated investors on its acquisition of New Zealand oil producer Matahio NZ, confirming the transaction remains on track to complete
UK stocks ended the week on a weaker footing. The FTSE 100 fell 0.4% to close at 10,363, leaving the blue-chip index down 1.0% for the week — its steepest
Sunda Energy plc (AIM: SNDA) has disclosed that it has received a notice from Timor-Leste’s upstream petroleum regulator indicating its intention to terminate the Production Sharing Contract covering the company’s
(Alliance News) – Keir Starmer has welcomed the ceasefire agreed between the US and Iran overnight and said it was an opportunity to secure a long-term solution for shipping through the
The Times: Share prices have risen and oil prices have fallen in overnight trading in Asia as markets seized on remarks by President Trump that the war in Iran is “very
GenIP (GNIP), the AI-powered innovation intelligence and technology commercialisation company, reported continued momentum across corporate and academic markets, building on the operational progress detailed in its January Corporate Update and reflecting
Sunda Energy Plc Awarded 37.5% Stake in Two Offshore Philippine Licence Areas
The Times: Shares in Close Brothers, Lloyds, Barclays and Investec will be in sharp focus this morning after the Financial Conduct Authority (FCA) published details of a proposed redress scheme following the car loan mis-selling scandal.
Sunda Energy Targets H1 2026 for Chuditch-2 Drilling
EDX Medical Group (AQSE:EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, cardiovascular and infectious diseases, announced that the Company is to launch a new highly
Rome Resources (RMR), the DRC-focused tin explorer, updated on drilling progress at the Mont Agoma Prospect, its polymetallic tin-copper-zinc prospect located in the North Kivu province in the Democratic Republic of
ImmuPharma (IMM), the specialist drug discovery and development company, announced its interim results for the six months ended 30 June 2024. On 3 June 2024. ImmuPharma divested its investment in shares